I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 13 studies | 19% ± 3% | |
| endothelial cell | 10 studies | 26% ± 8% | |
| glutamatergic neuron | 8 studies | 37% ± 25% | |
| oligodendrocyte precursor cell | 7 studies | 26% ± 6% | |
| platelet | 6 studies | 26% ± 6% | |
| CD16-positive, CD56-dim natural killer cell, human | 6 studies | 20% ± 4% | |
| neuron | 6 studies | 28% ± 10% | |
| macrophage | 6 studies | 20% ± 3% | |
| GABAergic neuron | 6 studies | 37% ± 20% | |
| fibroblast | 5 studies | 22% ± 7% | |
| epithelial cell | 5 studies | 36% ± 14% | |
| astrocyte | 5 studies | 28% ± 5% | |
| oligodendrocyte | 5 studies | 23% ± 5% | |
| non-classical monocyte | 4 studies | 19% ± 4% | |
| hematopoietic precursor cell | 4 studies | 24% ± 5% | |
| retina horizontal cell | 4 studies | 25% ± 10% | |
| interneuron | 4 studies | 38% ± 22% | |
| microglial cell | 3 studies | 17% ± 1% | |
| smooth muscle cell | 3 studies | 21% ± 4% | |
| amacrine cell | 3 studies | 32% ± 11% | |
| retinal rod cell | 3 studies | 22% ± 3% | |
| ciliated cell | 3 studies | 32% ± 7% | |
| CD8-positive, alpha-beta T cell | 3 studies | 16% ± 1% | |
| dendritic cell | 3 studies | 24% ± 4% | |
| granulocyte monocyte progenitor cell | 3 studies | 22% ± 2% | |
| megakaryocyte | 3 studies | 29% ± 10% | |
| basal cell | 3 studies | 32% ± 8% | |
| transit amplifying cell | 3 studies | 22% ± 6% |
